Searched for
CADILA HEALTHCARE RESULTS
These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- Cadila Healthcare Q3 Results: Firm posts 5% decline in profit at Rs 500 crConsolidated total revenue from operations stood at Rs 3,655 crore during the quarter under review as compared to Rs 3,633 crore in the yea...
- Cadila Healthcare Q2 results: Net profit zooms over 6-fold to Rs 3,002 cr on one-time gainConsolidated total revenue from operations of the company stood at Rs 3,784.8 crore for the quarter under consideration. It was Rs 3,658.9 ...
- Cadila Healthcare Q4 results: Net profit up 73% at Rs 679 croreConsolidated total revenue from operations stood at Rs 3,846.7 crore for the quarter under consideration. It was Rs 3,752.1 crore for the s...
- Zydus Cadila seeks DCGI nod for use of hepatitis drug for treating coronavirus casesThe interim results indicate that the drug when administered early on, could help patients recover faster and avoid much of the complicatio...
- Zydus Cadila says 'positive results' from phase 2 studies of COVID-19 drug Desidustat in MexicoIn June 2020, Zydus Cadila had received approval from Mexico's regulatory authority Cofepris to test one of its lead research candidate Des...
- CLSA maintains buy rating on Cadila Healthcare, target price Rs 285Buy Cadila Healthcare Ltd. at a price target of Rs 285.0 .
- Cadila Healthcare Q1 profit at Rs 304 croreTotal income from operations stood at Rs 3,496.3 crore for the quarter under consideration.
- Cadila Healthcare posts Q4 net profit of Rs 460 croreShares of Cadila Healthcare were trading at Rs 262.70 per scrip on the BSE
- Zydus and Pharm Aid Ltd. enter into an exclusive agreement for vaccine technology in RussiaThrough this agreement, Zydus gains access to the public and private market segments in the Russian Federation, Belarus, Uzbekistan, Kazakh...
- Cadila Healthcare, Torrent Pharma eyeing potential merger"More clarity on the proposed structure, valuations can be expected in the next six months," a source said adding that the merger may or ma...
- Outperform Cadila Healthcare Ltd., target Rs 405: Credit SuisseThe June quarter results are likely to remain weak given competition in HCQS, lower share in key drugs. Once Moraiya is cleared, Cadila sho...
- Cadila Healthcare gets EIR from USFDA for Moraiya facility"What is 'closed' is the initial review that resulted in the warning letter issuance," Cadila Healthcare said.
- FIPB clears Cadila Healthcare, 8 other proposalsInter-ministerial body FIPB today cleared nine proposals including that of Cadila Healthcare and Volvo Asset Finance India.
- Cadila Healthare shares surge nearly 6% on smart earningsShares of Cadila Healthcare today surged nearly 6 per cent after pharma firm reported 81.54 per cent increase in consolidated net profit fo...
- Cadila tanks 9% on weak Q3 results, brokerage downgradesCadila Healthcare slipped nearly 9 per cent in early trade on Monday after the company reported 31% dip in consolidated net profit.
- Cadila Q4 net dips 4.52% to Rs 171 croreThe company had posted a net profit of Rs 178.97 crore for in the same quarter last fiscal, Cadila Healthcare said in a filing to BSE.
- Accumulate Cadila Healthcare for target of Rs 350: AngelAngel Broking has recommended accumulating shares of Cadila Healthcare in its results preview analysis.
Load More
